Government & Policy Update
Maxer Consulting (Italy), in collaboration with Paarlberg and Associates (US), is pleased to present the monthly Government & Policy Update (G&PU). The G&PU encompasses the most relevant updates in drug development, regulatory affairs, clinical trial disclosure, medical marketing, health technology assessment, pharmacovigilance, and other key topics in the ever-changing international pharmaceutical landscape.
By monitoring and assessing a broad range of sources, G&PU summarises the most important regulatory, policy, drug development and clinical trial monthly news in the pharma sector.
The essential structure of the G&PU allows a quick but detailed overview of the international pharmaceutical environment. The G&PU is thus a particularly useful tool to support ‘in-house’ intelligence and to keep company management and the professionals informed who work in the areas of competence mentioned above.
Whether you and your colleagues are interested in further receiving the G&PU, we can propose to you an extremely competitive subscription conditions: the one company, one subscription formula that eliminates unnecessary calculations for the transfer of multiple licenses.
